Pancreatic Cancer Research

ResearcherUniversity Hospital Centre ZagrebNo recent work listed

Juraj Prejac

Matched on ORCID iD 0000-0003-1981-9369; OpenAlex author ID A5088648639.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
2 (first author 1, last author 0)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Collaborators
3
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. The effectiveness of nab-paclitaxel plus gemcitabine and gemcitabine monotherapy in first-line metastatic pancreatic cancer treatment: A real-world evidence. First author DOI 10.1097/md.0000000000030566↗
  2. [CANCER PATIENTS FOLLOW-UP – CROATIAN SOCIETY OF MEDICAL ONCOLOGY CLINICAL GUIDELINES Part III: neuroendocrine neoplasms, hepatocellular carcinoma, pancreatic … Co-author PMID 30091882↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Stjepko Pleština · 1 shared paper, 2022
  2. Damir Vrbanec · 1 shared paper, 2016
  3. Natalija Dedić Plavetić · 1 shared paper, 2016

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.